Improved confinement in TEXTOR
J. Ongena(Royal Military Academy), G.H. Wolf, H. Conrads(Forschungszentrum Jülich), G. Mank, R. Van Nieuwenhove, W. Kohlhaas(Royal Military Academy), G. Waidmann, R. Uhlemann, B. Schweer(Forschungszentrum Jülich), P. Hüttemann, G. Telesca(Institute of Plasma Physics and Laser Microfusion), M. Gaigneaux(Royal Military Academy), H. Euringer, H. Kever(Forschungszentrum Jülich), M. Korten(Forschungszentrum Jülich), H. R. Koslowski(Forschungszentrum Jülich), Michel Jadoul(Cliniques Universitaires Saint-Luc), P. E. Vandenplas, H. Soltwisch, F. Durodié, A. Krämer-Flecken(Forschungszentrum Jülich), E. P. Barbian(Royal Military Academy), F. Hoenen, A. Messiaen(Royal Military Academy), G. Van Oost(Ghent University), Thierry Delvigne(Royal Military Academy), G. Van Wassenhove, P. Dumortier(Royal Military Academy), U. Samm(Forschungszentrum Jülich), R.R. Weynants, M. Lochter, B. Giesen, E. Graffmann(Forschungszentrum Jülich), L. Könen, R. Budny(Princeton Plasma Physics Laboratory), G. Fuchs, M. Vervier, R. Koch, A. Pospieszczyk(Forschungszentrum Jülich), H.G. Esser, J. Winter(Ruhr University Bochum), G. Bertschinger(Forschungszentrum Jülich), D. L. Hillis(Oak Ridge National Laboratory), P Borgermans(Royal Military Academy)
Cited by 27
Related Papers
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
|Kidney International|2007|1.5k
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
|The Lancet|2019|620
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
|Journal of the American Society of Nephrology|2017|599